Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $109.00

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) has been given an average recommendation of "Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $109.00.

Several equities analysts have recently weighed in on the company. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. JMP Securities restated a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research restated an "outperform" rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Finally, JPMorgan Chase & Co. reduced their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th.

U.S. Physical Therapy Stock Down 0.2%

USPH traded down $0.19 during trading on Friday, reaching $76.56. The stock had a trading volume of 196,333 shares, compared to its average volume of 123,128. The stock's 50 day moving average is $76.48 and its two-hundred day moving average is $79.29. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of 35.12, a P/E/G ratio of 3.72 and a beta of 1.44. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same period last year, the company earned $0.51 earnings per share. The company's revenue was up 18.0% on a year-over-year basis. As a group, analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.35%. U.S. Physical Therapy's payout ratio is 82.57%.

Insider Buying and Selling

In related news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. This trade represents a 13.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of U.S. Physical Therapy by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company's stock valued at $96,179,000 after purchasing an additional 6,393 shares during the period. Southernsun Asset Management LLC grew its stake in shares of U.S. Physical Therapy by 4.5% during the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock valued at $50,725,000 after purchasing an additional 24,698 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of U.S. Physical Therapy by 1.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock valued at $37,818,000 after purchasing an additional 7,890 shares during the period. Bahl & Gaynor Inc. grew its stake in shares of U.S. Physical Therapy by 32.6% during the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock valued at $24,964,000 after purchasing an additional 84,878 shares during the period. Finally, GW&K Investment Management LLC grew its stake in shares of U.S. Physical Therapy by 8.9% during the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company's stock valued at $24,920,000 after purchasing an additional 28,203 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.